Back to results
US 2022/0031675 A1Published application
Methods for treating irritable bowel syndrome (ibs)
AssigneeSalix Pharmaceuticals, Inc.
InventorsWilliam Forbes, Enoch Bortey
Life of this patent
Estimating the term…
Abstract
The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
Claims23
A method of treating Irritable Bowel Syndrome (IBS), comprising:
- administering 550 mg of rifaximin TID to a subject in need thereof,
- thereby treating Irritable Bowel Syndrome (IBS).
16-18. (canceled)
A method of treating IBS in older subjects comprising administering 550 mg of rifaximin TID to an older subject in need thereof, thereby treating IBS in older subjects.
20-26. (canceled)
A method of treating abdominal pain associated with Irritable Bowel Syndrome (IBS), comprising:
- administering 550 mg of rifaximin TID to a subject in need thereof,
- thereby treating abdominal pain Irritable Bowel Syndrome (IBS).
31-36. (canceled)
Dependencies are inferred from the claim text.